Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| ADEN_4_7 | ADENOVIRUS TYPES 4 & 7, LIVE, ORAL (NO BRAND NAME) | TEVA PHARMACEUTICALS | 1 | Y008591 | SYR / LA |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | K4JH7 | SYR / LA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 1 | X1D141M | SYR / RA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 1 | U8369BA | SYR / LA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | 1 | U8122AA | SYR / LA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y015559 | SYR / RA |
Patient received vaccinations listed above at public health clinic on 4/1/2025. At the time of receiving vaccinations, it was unknown to patient and provider that she was pregnant, approximately 16 weeks gestational age. Patient later discovered pregnancy on 5/5/2025 during emergency room visit.
None
None
None
No known allergies
ER visit, 5/5/2025. Ultrasound verification of intrauterine pregnancy, approximately 21 weeks gestational age.